Perrigo Company PLC Receives “Buy” Rating from Jefferies Group (PRGO)
Perrigo Company PLC (NASDAQ:PRGO)‘s stock had its “buy” rating reiterated by analysts at Jefferies Group in a research report issued to clients and investors on Tuesday, Analyst Ratings.Net reports. They currently have a $180.00 price objective on the stock. Jefferies Group’s price target suggests a potential upside of 23.55% from the stock’s previous close.
Shares of Perrigo Company PLC (NASDAQ:PRGO) traded down 0.92% on Tuesday, hitting $145.69. The stock had a trading volume of 850,765 shares. Perrigo Company PLC has a 52-week low of $112.05 and a 52-week high of $168.39. The stock has a 50-day moving average of $153.0 and a 200-day moving average of $151.8. The company has a market cap of $19.486 billion and a price-to-earnings ratio of 54.99.
Perrigo Company PLC (NASDAQ:PRGO) last posted its quarterly earnings results on Thursday, February 6th. The company reported $1.87 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.59 by $0.28. The company had revenue of $979.00 million for the quarter, compared to the consensus estimate of $996.68 million. During the same quarter in the previous year, the company posted $1.36 earnings per share. The company’s revenue for the quarter was up 10.9% on a year-over-year basis. On average, analysts predict that Perrigo Company PLC will post $6.61 earnings per share for the current fiscal year.
The company also recently declared a quarterly dividend, which is scheduled for Tuesday, June 17th. Stockholders of record on Friday, May 30th will be given a dividend of $0.105 per share. This represents a $0.42 dividend on an annualized basis and a yield of 0.29%.
A number of other firms have also recently commented on PRGO. Analysts at Zacks reiterated a “neutral” rating on shares of Perrigo Company PLC in a research note on Friday, April 4th. They now have a $160.00 price target on the stock. Separately, analysts at Goldman Sachs raised their price target on shares of Perrigo Company PLC from $157.00 to $165.00 in a research note on Tuesday, March 4th. Finally, analysts at Morgan Stanley reiterated an “overweight” rating on shares of Perrigo Company PLC in a research note on Monday, March 3rd. They now have a $167.00 price target on the stock. One research analyst has rated the stock with a sell rating, two have issued a hold rating, ten have issued a buy rating and one has given a strong buy rating to the company. Perrigo Company PLC presently has an average rating of “Buy” and a consensus price target of $167.55.
Perrigo Company plc is a global healthcare supplier that develops, manufactures and distributes over-the-counter (NASDAQ:PRGO) and generic prescription (Rx) pharmaceuticals, infant formulas, nutritional products, animal health, dietary supplements, active pharmaceutical ingredients (API), and medical diagnostic products, and Multiple Sclerosis drug Tysabri.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.